Annette Alaeus

1.6k total citations
26 papers, 1.3k citations indexed

About

Annette Alaeus is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Annette Alaeus has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 16 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Annette Alaeus's work include HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (8 papers). Annette Alaeus is often cited by papers focused on HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (8 papers). Annette Alaeus collaborates with scholars based in Sweden, United States and Denmark. Annette Alaeus's co-authors include Jan Albert, Knut Lidman, Karolin Falconer, Johan K. Sandberg, Thomas Leitner, Anders Sönnerborg, Olle Reichard, Kim Blom, Veronica D. Gonzalez and Åsa Björndal and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Annette Alaeus

26 papers receiving 1.2k citations

Peers

Countries citing papers authored by Annette Alaeus

Since Specialization

Citations

This map shows the geographic impact of Annette Alaeus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Alaeus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Alaeus more than expected).

Fields of papers citing papers by Annette Alaeus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Alaeus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Alaeus. The network helps show where Annette Alaeus may publish in the future.

Co-authorship network of co-authors of Annette Alaeus

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Alaeus. A scholar is included among the top collaborators of Annette Alaeus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Alaeus. Annette Alaeus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality 2011 ·PLoS ONE ·(unknown), Ryan N. Gutenkunst, Karin Wilbe Ramsay, Annette Alaeus, Jan Albert, Thomas Leitner	5
2	Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden 2011 ·Scandinavian Journal of Infectious Diseases ·Per-Olof Thuresson, Bart Heeg, Bénédicte Lescrauwaet, Karin Sennfält, Annette Alaeus, Aljoscha S. Neubauer	6
3	IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV 2010 ·Scandinavian Journal of Infectious Diseases ·Karolin Falconer, Galia Askarieh, Nina Weis, Kristoffer Hellstrand, Annette Alaeus, Martin Lagging, (unknown)	27
4	High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment 2009 ·Journal of Virology ·Verónica González, Karolin Falconer, Kim Blom, Olle Reichard, Birgitte Mørn, Alex Lund Laursen, Nina Weis, Annette Alaeus, Johan K. Sandberg	123
5	HCV/HIV co-infection at a large HIV outpatient clinic in Sweden: Feasibility and results of hepatitis C treatment 2009 ·Scandinavian Journal of Infectious Diseases ·Karolin Falconer, Johan K. Sandberg, Olle Reichard, Annette Alaeus	6
6	Elevated Numbers of FcγRIIIA+ (CD16+) Effector CD8 T Cells with NK Cell-Like Function in Chronic Hepatitis C Virus Infection 2008 ·The Journal of Immunology ·Niklas K. Björkström, Veronica D. Gonzalez, Karl‐Johan Malmberg, Karolin Falconer, Annette Alaeus, Greg Nowak, Carl Jorns, Bo‐Göran Ericzon, Ola Weiland, Johan K. Sandberg, Hans‐Gustaf Ljunggren	56
7	Expansion of CD56− NK cells in chronic HCV/HIV-1 co-infection: Reversion by antiviral treatment with pegylated IFNα and ribavirin 2008 ·Clinical Immunology ·Veronica D. Gonzalez, Karolin Falconer, Jakob Michaëlsson, Markus Moll, Olle Reichard, Annette Alaeus, Johan K. Sandberg	52
8	Therapeutic immunization for HIV 2006 ·Springer Seminars in Immunopathology ·Lindvi Gudmundsdotter, Anna Sjödin, (unknown), Bo Hejdeman, (unknown), Annette Alaeus, Knut Lidman, Britta Wahrén	14
9	Impact of HIV Type 1 Genetic Subtype on the Outcome of Antiretroviral Therapy 2005 ·AIDS Research and Human Retroviruses ·Ann Atlas, Fredrik Granath, Anna Lindström, Knut Lidman, Stefan Lindbäck, Annette Alaeus	33
10	Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV‐1 subtypes A–D 2004 ·Journal of Medical Virology ·Ann Atlas, (unknown), Anna Lindström, Anna Nilsson, Annette Alaeus, Francesca Chiodi, Angelo De Milito	11
11	Limited Transmission of Drug-Resistant HIV Type 1 in 100 Swedish Newly Detected and Drug-Naive Patients Infected with Subtypes A, B, C, D, G, U, and CRF01_AE 2003 ·AIDS Research and Human Retroviruses ·Irina Maljkovic Berry, Karin Wilbe Ramsay, (unknown), Annette Alaeus, Thomas Leitner	16
12	Chronic Hepatitis C: Updated Swedish Consensus 2003 ·Scandinavian Journal of Infectious Diseases ·Rune Wejstål, Annette Alaeus, Björn Fischler, Olle Reichard, Ingrid Uhnoo, Ola Weiland	14
13	Assay of Plasma Samples Representing Different HIV-1 Genetic Subtypes: An Evaluation of New Versions of the Amplicor HIV-1 Monitor Assay 1999 ·AIDS Research and Human Retroviruses ·Annette Alaeus, (unknown), Steven A. Herman, Joanne P. Spadoro, June Wang, Jan Albert	24
14	Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D 1999 ·AIDS ·Annette Alaeus, Knut Lidman, Anders Björkman, Johan Giesecke, Jan Albert	81
15	Characterization of subtype A HIV-1 from Africa by full genome sequencing 1999 ·AIDS ·Jean K. Carr, Tiina Laukkanen, Mika Salminen, Jan Albert, Annette Alaeus, Bohye Kim, Eric Sanders‐Buell, Deborah L. Birx, Francine E. McCutchan	81
16	Differences in Chemokine Coreceptor Usage between Genetic Subtypes of HIV-1 1998 ·Virology ·Charlotte Tscherning, Annette Alaeus, Robert Fredriksson, Åsa Björndal, Hongkui Deng, Dan R. Littman, Éva Mária Fenyõ, Jan Albert	209
17	Drug Susceptibility of Subtypes A, B, C, D, and E Human Immunodeficiency Virus Type 1 Primary Isolates 1998 ·AIDS Research and Human Retroviruses ·Sarah E. Palmer, Annette Alaeus, Jan Albert, Susan M. Cox	84
18	Most HIV-1 genetic subtypes have entered Sweden 1997 ·AIDS ·Annette Alaeus, Thomas Leitner, Knut Lidman, Jan Albert	99
19	Subtype-specific problems with quantification of plasma HIV-1 RNA 1997 ·AIDS ·Annette Alaeus, Knut Lidman, Anders Sönnerborg, Jan Albert	122
20	Branhamella catarrhalis septicemia in an immunocompetent adult 1991 ·Scandinavian Journal of Infectious Diseases ·Annette Alaeus, G Stiernstedt	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact